Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arterys developed the world’s first internet-based medical imaging cloud platform powered by artificial intelligence. Its FDA-cleared and CE-marked solutions provide rapid, accurate quantification and interpretation of radiological images for cardiovascular disease, oncology, and other specialties. The company’s core products include Cardio AI for cardiac MRI analysis and Lung AI for lung nodule detection. In November 2022, Arterys was acquired by Tempus to become part of its precision medicine ecosystem. As a result, its technology now supports one of the world’s largest multimodal data platforms for healthcare providers and researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arterys.